Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Divi's Laboratories (DIVI IN)
Watchlist
71
Analysis
Health Care
•
India
Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Voltas Ltd
•
23 Oct 2024 06:50
NIFTY200 Momentum30 Index Rebalance Preview: 56% Turnover, Big Trade & Strong Momentum
There could be 16 constituent changes in December. one-way turnover is estimated at 55.6% and that will result in a one-way trade of INR 62bn...
Brian Freitas
Follow
527 Views
Share
bullish
•
NIFTY Index
•
05 Oct 2024 07:00
EQD | Is the NIFTY A BUY Here?
The NIFTY Index closed the week down, now the question is: IS THIS A GOOD TIME TO (RE)ENTER LONG? As always, the Market Reversal Matrix models...
Nico Rosti
Follow
589 Views
Share
bearish
•
NTPC Ltd
•
26 Sep 2024 09:54
NIFTY Indices: Flows (Post Capping) At the Close Tomorrow; Round-Trip US$3.3bn
The next rebalance of the Nifty family of indices takes place at the close on 27 Sep. The round-trip trade is US$3.3bn and there are 13 stocks with...
Brian Freitas
Follow
437 Views
Share
bullish
•
Bharat Heavy Electricals
•
26 Aug 2024 05:50
NIFTY NEXT50 Index Rebalance: 7 Changes on Expected Lines
There are 7 changes for the NIFTY Next50 Index. Estimated 1-way turnover is 19.6% resulting in a 1-way trade of INR 63.64bn (US$759m). There are...
Brian Freitas
Follow
476 Views
Share
bullish
•
Trent Ltd
•
25 Aug 2024 08:00
NIFTY50 Index Rebalance: Trent, BEL to Replace Divi's Lab, LTIMindtree
Trent and Bharat Electronics will replace LTIM and Divi Lab in the NIFTY50. There is over 5x ADV/11x delivery volume to trade in the stocks. There...
Brian Freitas
Follow
469 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x